BCL2L1 and B-cell chronic lymphocytic leukemia: Although Bcl‐XL is regulated by both canonical and non‐canonical NF‐κB pathways in CLL, the non‐canonical NF‐κB pathway is the dominant signalling route for prolonged expression of Bcl‐XL [13].